About this Research Topic
Cardiogenic thrombotic stroke (CES), also known as cardiogenic stroke, refers to a clinical syndrome wherein emboli originating from the heart and aortic arch leads to cerebral artery embolism through circulation, resulting in corresponding brain dysfunction. Compared with ischemic stroke caused by other factors, cardiogenic stroke exhibits a more complex etiology, a relatively severe clinical state, and a poorer prognosis. Therefore, understanding the etiology, correct diagnosis, and standardized treatment of CES are of great significance for its secondary prevention. Many heart diseases can contribute to the occurrence of CES, including commonly observed causes such as atrial fibrillation, recent myocardial infarction, artificial heart valves, dilated cardiomyopathy, rheumatic mitral stenosis, infectious endocarditis, and atrial myxoma. In addition, in recent years, substantial research focusing on patent foramen ovale (PFO) and aortic valve calcification stenosis suggests that they are important reasons for cardiogenic stroke.
Early diagnosis plays a crucial role in addressing the different causes of CES. With the continuous development of evidence-based medical approaches such as left atrial appendage occlusion (LAAO) and patent foramen ovale occlusion (PFOO), alongside the application of novel devices, interventional prevention of cardiogenic stroke has gradually become a research hotspot.
In this research topic, we would like to create a forum to systematically introduce the etiological diagnosis and recent advances in imaging diagnosis of CES, including standardized diagnostic approaches utilizing ultrasound imaging and radiological imaging techniques, as well as discuss comprehensively on the interventional prevention of CES, especially the clinical application of LAA and PFO closure, invasive and non-invasive imaging, step-by-step procedural guidance, and insights from esteemed experts within the field.
We welcome submissions on the following topics, but are not limited to:
- Latest innovation and emerging procedures in congenital, structural interventions
- Application of new occluder (New concepts, new materials, etc.) in cardiogenic stroke
- Clinical likelihood of PFO/LAA and selection of imaging tests
- Drug therapy and interventional therapy for PFO/LAA
Early diagnosis plays a crucial role in addressing the different causes of CES. With the continuous development of evidence-based medical approaches such as left atrial appendage occlusion (LAAO) and patent foramen ovale occlusion (PFOO), alongside the application of novel devices, interventional prevention of cardiogenic stroke has gradually become a research hotspot.
In this research topic, we would like to create a forum to systematically introduce the etiological diagnosis and recent advances in imaging diagnosis of CES, including standardized diagnostic approaches utilizing ultrasound imaging and radiological imaging techniques, as well as discuss comprehensively on the interventional prevention of CES, especially the clinical application of LAA and PFO closure, invasive and non-invasive imaging, step-by-step procedural guidance, and insights from esteemed experts within the field.
We welcome submissions on the following topics, but are not limited to:
- Latest innovation and emerging procedures in congenital, structural interventions
- Application of new occluder (New concepts, new materials, etc.) in cardiogenic stroke
- Clinical likelihood of PFO/LAA and selection of imaging tests
- Drug therapy and interventional therapy for PFO/LAA
Keywords: cardiogenic stroke, atrial fibrillation, patent foramen ovale, intervention, prevention
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
